![Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center - ScienceDirect Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0720048X19300804-gr2.jpg)
Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center - ScienceDirect
![PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram](https://www.researchgate.net/publication/348240795/figure/fig2/AS:982331863080969@1611217575943/PI-RADS-III-prostate-cancer-a-Axial-T2-WI-shows-TZ-heterogeneous-signal-intensity-with.png)
PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram
![Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions - European Urology Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/927ebe7b-9061-49a3-81f9-36009ec2ff0c/gr1_lrg.jpg)
Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions - European Urology
![Frontiers | Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions Frontiers | Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions](https://www.frontiersin.org/files/Articles/840786/fonc-12-840786-HTML-r1/image_m/fonc-12-840786-g001.jpg)
Frontiers | Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
![Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - European Urology Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aef91c09-51a8-4a54-896c-e81c84f07277/gr4_lrg.jpg)
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - European Urology
![Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients - European Journal of Radiology Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients - European Journal of Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a43db861-2388-4b3c-a429-c870521da8d2/gr1_lrg.jpg)
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients - European Journal of Radiology
![PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway | Radiology PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2019182946/asset/images/medium/radiol.2019182946.fig3.gif)
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway | Radiology
![PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract](https://www.urotoday.com/images/pirads-3_graphical_abstract.png)
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
![Risk Stratification of Prostate Cancer According to PI-RADS® Version 2 Categories: Meta-Analysis for Prospective Studies | Journal of Urology Risk Stratification of Prostate Cancer According to PI-RADS® Version 2 Categories: Meta-Analysis for Prospective Studies | Journal of Urology](https://www.auajournals.org/cms/asset/1abb6d80-d0b1-436b-b084-0ed626f76b63/ju.0000000000001306f3.gif)
Risk Stratification of Prostate Cancer According to PI-RADS® Version 2 Categories: Meta-Analysis for Prospective Studies | Journal of Urology
![In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43055-021-00543-9/MediaObjects/43055_2021_543_Fig2_HTML.png)
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text
![Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology](https://www.auajournals.org/cms/asset/472738d8-800f-4e0f-beec-1b864edf6d9e/abs-fig.jpg)
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
![Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-10859-9/MediaObjects/41598_2022_10859_Fig1_HTML.png)
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
![MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology](https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/18050/public/18050-PB3-R1.png/w300)
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
![JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies | HTML JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies | HTML](https://www.mdpi.com/jpm/jpm-10-00270/article_deploy/html/images/jpm-10-00270-g001.png)
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies | HTML
![MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology](https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/18050/public/18050-PB8-R1.png/w300)